Shukra Pharmaceuticals Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 7.25 | 39.95 | 7.59 |
| Operating Expense | 5.62 | 12 | 6.30 |
| Net Profit | -1.73 | 20.36 | 2.38 |
| Net Profit Margin | -23.86% | 50.96% | 31.36% |
| Earning Per Share | -0.04 | 0.47 | 0.05 |
| EBIDTA | 3.97 | 25.59 | 3.48 |
| Effective Tax Rate | 271.78% | 14.70% | 0% |
Particulars
Mar 2026
Revenue7.25
Operating Expense5.62
Net Profit-1.73
Net Profit Margin-23.86
Earning Per Share-0.04
EBIDTA3.97
Effective Tax Rate271.78
